These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 22640511

  • 21. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW, Abate G, Lakew M, Goshu S, Aseffa A.
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [Abstract] [Full Text] [Related]

  • 22. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
    Augustynowicz-Kopeć E, Zwolska Z, Jaworski A, Kostrzewa E, Klatt M, Swiderska A, Drozd I.
    Pneumonol Alergol Pol; 2002 Jul; 70(3-4):193-202. PubMed ID: 12271966
    [Abstract] [Full Text] [Related]

  • 23. Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment.
    Ramarokoto H, Randriamiharisoa H, Rakotoarisaonina A, Rasolovavalona T, Rasolofo V, Chanteau S, Ralamboson M, Cauchoix B, Rakotondramarina D.
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):909-12. PubMed ID: 12365578
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Multiplex allele specific PCR for rapid detection of extensively drug resistant tuberculosis.
    Vadwai V, Shetty A, Rodrigues C.
    Tuberculosis (Edinb); 2012 May; 92(3):236-42. PubMed ID: 22342856
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
    Sangare L, Diande S, Kouanda S, Dingtoumda BI, Mourfou A, Ouedraogo F, Sawadogo I, Nebie B, Gueye A, Sawadogo LT, Traore AS.
    Ann Afr Med; 2010 May; 9(1):15-9. PubMed ID: 20418644
    [Abstract] [Full Text] [Related]

  • 31. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P, Chitsaz E, Tabatabaei V, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Mansouri D, Masjedi MR, Velayati AA.
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [Abstract] [Full Text] [Related]

  • 32. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group.
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [Abstract] [Full Text] [Related]

  • 33. The management of tuberculosis: epidemiology, resistance and monitoring.
    Bang D.
    Dan Med Bull; 2010 Nov; 57(11):B4213. PubMed ID: 21055374
    [Abstract] [Full Text] [Related]

  • 34. [A controlled clinical trial of long course chemotherapy regimens containing rifabutin in the treatment of multi-drug resistant pulmonary tuberculosis].
    Zhu LZ, Fu Y, Chu NH, Ye ZZ, Xiao HP, Wang W, Yuan SL, Zhang X, Luo YA, Ma LP.
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):520-3. PubMed ID: 17074263
    [Abstract] [Full Text] [Related]

  • 35. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [Abstract] [Full Text] [Related]

  • 36. [A case of drug-resistant pulmonary tuberculosis treated successfully following disappearance of rifampicin resistance after 17 years' chemotherapy].
    Shigeto E, Murakami I, Yokosaki Y.
    Kekkaku; 2001 Apr; 76(4):379-83. PubMed ID: 11398329
    [Abstract] [Full Text] [Related]

  • 37. Rapid detection of smear-negative Mycobacterium tuberculosis by PCR and sequencing for rifampin resistance with DNA extracted directly from slides.
    Patnaik M, Liegmann K, Peter JB.
    J Clin Microbiol; 2001 Jan; 39(1):51-2. PubMed ID: 11136747
    [Abstract] [Full Text] [Related]

  • 38. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains].
    Han JP, Sun SL, Li RZ, Zhang FS, Wang SC, Cheng J, Deng YF, Wang Y, Yu CB.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):70-3. PubMed ID: 12783654
    [Abstract] [Full Text] [Related]

  • 39. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru.
    Chavez Pachas AM, Blank R, Smith Fawzi MC, Bayona J, Becerra MC, Mitnick CD.
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):52-8. PubMed ID: 14974746
    [Abstract] [Full Text] [Related]

  • 40. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
    Il'iuna TIa, Zhangireev AA, Sidorenko OA.
    Probl Tuberk Bolezn Legk; 2008 Jan; (5):20-2. PubMed ID: 18711814
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.